Development
Alnylam Pharmaceuticals, Inc.
ALNY
$300.83
-$7.17-2.33%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.27% | 6.22% | -2.52% | -7.54% | -9.98% |
| Total Receivables | 37.75% | 76.38% | 55.08% | 40.18% | 19.84% |
| Inventory | -30.87% | -17.07% | 12.90% | 67.96% | 49.33% |
| Prepaid Expenses | -4.92% | 25.85% | 12.08% | 3.45% | 50.91% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 10.79% | 10.95% | 2.12% | -1.88% | -4.14% |
|
|
|||||
| Total Current Assets | 10.79% | 10.95% | 2.12% | -1.88% | -4.14% |
| Net Property, Plant & Equipment | -1.74% | -0.62% | 0.57% | 0.67% | 0.68% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.12% | 12.42% | 12.17% | 1.92% | 14.23% |
| Total Assets | 7.99% | 8.59% | 2.16% | -1.21% | -2.66% |
|
|
|||||
| Total Accounts Payable | -43.40% | 82.00% | 13.98% | 13.33% | 33.60% |
| Total Accrued Expenses | 27.43% | 39.66% | 42.09% | 42.89% | 37.99% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 17.32% | 10.69% | 8.59% | 5.51% | 5.96% |
| Total Finance Division Other Current Liabilities | 118.25% | -46.51% | -52.19% | -72.85% | -57.18% |
| Total Other Current Liabilities | 118.25% | -46.51% | -52.19% | -72.85% | -57.18% |
| Total Current Liabilities | 26.03% | 22.90% | 19.91% | 11.13% | 10.38% |
|
|
|||||
| Total Current Liabilities | 26.03% | 22.90% | 19.91% | 11.13% | 10.38% |
| Long-Term Debt | 3.26% | 3.68% | 22.48% | 23.12% | 24.21% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -6.98% | -6.99% | -6.84% | -6.49% | -7.11% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 22.21% | 50.93% | 35.64% | 49.12% | 61.69% |
| Total Liabilities | 9.34% | 11.16% | 20.80% | 20.41% | 21.26% |
|
|
|||||
| Common Stock & APIC | 5.52% | 6.31% | 7.68% | 6.63% | 6.54% |
| Retained Earnings | -6.70% | -8.01% | -17.86% | -18.75% | -20.80% |
| Treasury Stock & Other | 47.65% | 26.14% | 12.18% | -2.78% | -34.26% |
| Total Common Equity | -39.45% | -145.23% | -331.84% | -164.62% | -126.90% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -39.45% | -145.23% | -331.84% | -164.62% | -126.90% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -39.45% | -145.23% | -331.84% | -164.62% | -126.90% |
|
|
|||||